Detalhe da pesquisa
1.
Mass spectrometry detection of inhaled drug in distal fibrotic lung.
Respir Res;
23(1): 118, 2022 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35546672
2.
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvß6 integrin inhibitor.
Respir Res;
21(1): 75, 2020 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32216814
3.
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.
Respir Res;
20(1): 238, 2019 Oct 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31666084
4.
Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD.
Int J Chron Obstruct Pulmon Dis;
13: 203-215, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29386889
5.
A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD.
ERJ Open Res;
2(2)2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27730198
6.
Interpreting patient-reported outcomes from clinical trials in COPD: a discussion.
Int J Chron Obstruct Pulmon Dis;
11: 3069-3078, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27994447
7.
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD.
Int J Chron Obstruct Pulmon Dis;
11: 719-30, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27103795
8.
Relationship Between FEV1 and Patient-Reported Outcomes Changes: Results of a Meta-Analysis of Randomized Trials in Stable COPD.
Chronic Obstr Pulm Dis;
3(2): 519-538, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28848877